2025-01-26 - Analysis Report
## Colgate-Palmolive Co (CL) Stock Analysis Report

**1. Performance Relative to S&P 500 (VOO):**

Colgate-Palmolive Co (CL) is a multinational consumer goods company that manufactures and sells oral hygiene, personal care, and home care products.  The cumulative return of CL over the period analyzed is 35.06%, while the S&P 500 (VOO) returned 52.12%.  Therefore, CL underperformed VOO by **17.06 percentage points**.  The relative underperformance (compared to the historical range of -17.5% to 28.3%) is at the 9th percentile (0.9 out of 10).

**Alpha and Beta Analysis:**  The provided data shows inconsistent alpha and beta values, suggesting variability in performance relative to the market. While the beta consistently hovers around 1.0 (indicating similar volatility to the market), the alpha fluctuates between significantly positive and negative values, implying inconsistent outperformance or underperformance compared to the market's benchmark. The CAGR values also fluctuate, reflecting this volatility.  The Maximum Drawdown (MDD) remains relatively consistent around 9.3%, except for the 2023-2025 period which experiences a significantly higher MDD of 22%. This highlights the risk associated with the stock.  Capitalization (Cap) shows steady growth.

**2. Recent Price Movement:**

* **Closing Price:** $87.88
* **5-Day Moving Average:** $87.95
* **20-Day Moving Average:** $88.56
* **60-Day Moving Average:** $91.64

The stock price is currently trading below its 5, 20, and 60-day moving averages, suggesting a potential short-term downtrend. The recent price change (-$0.03) indicates a minor decline.

**3. Technical Indicators and Expected Return:**

* **RSI (36.04):**  Suggests the stock is currently in oversold territory, potentially signaling a buying opportunity.  However, further analysis is needed to confirm.
* **PPO (0.22):**  A positive PPO value suggests a bullish momentum, although a relatively low value.
* **Delta_Previous_Relative_Divergence (-4.6):** Indicates a recent decrease in the relative strength of CL compared to VOO.
* **Expected Return (461.8%):**  This exceptionally high expected return needs careful consideration. The data source and methodology for this calculation are crucial for accurate interpretation.  It likely indicates the potential for significant long-term growth, assuming a buy-and-hold strategy with a two-year minimum timeframe.  The high return is likely derived from a combination of future anticipated growth and the current undervalued state based on the RSI and price relative to moving averages.

**4. Recent Earnings Analysis:**

| Date       | EPS  | Revenue     |
|------------|------|-------------|
| 2024-10-25 | $0.9 | $5.03B      |
| 2024-07-26 | $0.89| $5.06B      |
| 2024-04-26 | $0.83| $5.07B      |
| 2023-10-27 | $0.86| $4.92B      |
| 2024-10-25 | $0.86| $4.92B      |

There's a slight inconsistency in the October 2024 entries; one has EPS $0.9 and the other $0.86.  Assuming the $0.9 figure is correct, EPS shows a generally upward trend over the past year, although the most recent quarter's increase is modest. Revenue remains relatively stable, exhibiting slight fluctuations.  The data needs clarification regarding the duplicate entries in Oct 2024.

**5. Financial Information:**

**Revenue and Profitability:** Revenue has remained fairly stable, fluctuating slightly around the $5B mark. Profit margins are high and consistently above 58%, indicating strong profitability.

**Capital and Profitability:** Equity and Return on Equity (ROE) show significant volatility across quarters.  The exceptionally high and negative ROE values in certain quarters warrant further investigation, potentially pointing towards accounting practices or unusual one-time events impacting the figures. These need thorough analysis to understand their implications.


**7. Overall Analysis:**

CL exhibits a mixed performance picture.  While exhibiting relatively consistent revenue and high profit margins, its stock price has recently underperformed the S&P 500, currently trading below key moving averages.  Technical indicators suggest potential for a rebound (oversold RSI), but the recent relative underperformance and volatile ROE figures raise concerns. The exceptionally high predicted long-term return should be viewed with skepticism, needing further verification of the underlying assumptions and calculation methodology. A comprehensive investigation into the inconsistencies in the provided data (duplicate October 2024 earnings, volatile ROE) is crucial for a complete and accurate assessment.  Further due diligence, including an evaluation of the company's future growth prospects and competitive landscape, is recommended before making any investment decisions.
